Keck Biotechnology Lab

Keck Mass Spectrometry Resource

Yale/NHLBI Proteomics Center

High Performance Computation

Yale Neuroscience Microarray Center

 

Site Index:


Yale/NIDA
Proteomics Center


Yale University
300 George Street
New Haven, CT 06511


Contact Us

   Yale University School of Medicine

NIDA Proteomics Center InvestigatorsArthur Simen, MD, PhD

Proteomic Analysis Of The Promoter Regions Of Genes Relevant To Substance Abuse And Dependence
Arthur Simen, MD, PhD, Divisions of Molecular Psychiatry, Aging Research, and Human Genetics, Yale University

Drug addiction is associated with changes in chromatin state. Drugs of abuse cause long-lasting changes in the state of proteins associated with DNA, including changes in transcription factor binding and changes in post-translational histone modifications, and these changes may underlie drug addiction. Risk factors for substance abuse, including genetic polymorphisms and stress also affect chromatin structure and function. Current methods for the study of DNA-protein interactions are limited to the study of single DNA regions and single proteins, or single proteins and multiple DNA regions. Methods for comprehensively studying protein occupancy and post-translational modifications of particular chromatin regions and the many proteins associated with these regions would significantly advance our understanding of genome regulation in addiction. New proteomics methods are ideally suited to characterizing the chromatin-associated proteome. Studies conducted to date have characterized alterations in transcription factor binding caused by a novel promoter variant of SLC6A1 that we discovered by resequencing. Here we propose to develop this methodology further and extend it to the study of native chromatin. Briefly, we propose to use tiled, biotin labeled oligonucleotide libraries to isolate chromatin regions of interest from brain regions implicated in drug addiction from rodent models of addiction and vulnerability to drug taking. Protein isolated from these chromatin fragments will be analyzed by iTraq and MIDAS to quantitatively characterize the spectrum of proteins associated with the chromatin region and to quantify post-translational histone modifications. This methodology will allow for a large improvement in the resolution of chromatin analysis in relation to addictive behavior and is likely to lead to many novel insights that would be impossible without the availability of powerful new proteomics tools.


    Top of Page
Medical Center

Yale-New Haven Hospital

Yale University

Copyright © 2004 - 2006, Yale University, New Haven, Connecticut, USA. All rights reserved.
Comments or suggestions to Greg Blasko.

Last modified: 23-May-2008 (GB)